The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment…
Enriqueta Felip
Honoring the legacy of Heine Hoi Hansen and his global contribution to lung cancer research and education, the Heine H….
Clarivate, a global leader in connecting people and organizations to intelligence to transform the world, has revealed its list of…
Inaugurated by Andrés Cervantes (Valencia, Spain), President of the European Society for Medical Oncology (ESMO) and ESMO Congress 2023, this…
Results of exploratory analysis of overall survival data from the pivotal phase III IMpower010 study were presented on the ground…
In recognition of multidisciplinary integrated cancer care, translational and clinical cancer research of excellence at the Vall d’Hebron University Hospital…
Advancing precision medicine in lung cancer, several studies (co) led by VHIO investigators have been presented, discussed, and debated at…
Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and…
Dr Enriqueta Felip, head of the Thoracic Tumours and Head and Neck Cancer Group at VHIO and section head in…
The first pre-specified interim analysis of overall survival data from the phase III IMpower010 trial shows a trend in favor…
